Meet Our Featured Speakers
THE FORUM FOR METABOLIC MEDICINE AND TREATMENT DEVELOPMENT
Welcome to the Metabolic Medicine Summit 2026, an event that brings together industry leaders and healthcare innovators committed to advancing metabolic therapies, technologies, and clinical strategies that are shaping the future of metabolic health.
Metabolic medicine faces significant challenges in turning advancements in gene editing, biomarkers, and precision therapies into meaningful clinical outcomes. This summit will highlight innovative approaches that aim to improve patient care and treatment.
Join us to gain practical insights, connect with global leaders, and help shape the future of metabolic health through innovation and collaboration.
key topics for
Emerging trends in metabolic therapies and patient-centered care
Innovative precision therapies targeting individual metabolic needs, along with patient-centered care models, are transforming treatment strategies worldwide.
Advancing biomarker-based research to enhance clinical outcomes
Biomarker research supports precise, effective treatments by identifying disease-specific markers that enhance outcomes and personalize care.
Case studies and clinical trials on therapies for metabolic disorders
Clinical trial data and case studies demonstrate the safety, effectiveness, and real-world impact of emerging therapies for metabolic disorders.
Breakthrough in therapeutic approaches for obesity and metabolic disorders
Advanced therapies for obesity and related metabolic dysfunctions using emerging drug platforms to improve health outcomes.
Innovations in biosimilars and peptide drugs for advanced treatments
Biosimilars and peptides provide cost-effective alternatives, as well as innovative therapies, for managing complex metabolic disorders.
Shaping metabolic medicine with global compliance and regulatory standards
New guidelines ensure the safety, effectiveness, and quality of metabolic therapies, aligning treatment practices with global standards to improve patient care and outcomes.
INDUSTRY TOPICS
NETWORKING EVENTS
LEADING EXPERTS
Q&A SESSIONS
Latest News
INVESTMENT
12 Jan 2026
Lilly’s Ventyx Deal Points to a Future Beyond InjectionsMARKET TRENDS
8 Jan 2026
Oral Weight Loss Pills Are Shaking Up Metabolic CarePARTNERSHIPS
6 Jan 2026
Pfizer’s Metsera Deal Ignites a New Obesity Drug Arms RaceRESEARCH
19 Dec 2025
Liver-First Drugs Redefine the Next Phase of the MASH Race
FDA Pilot Voucher Signals Faster Reviews for Metabolic Drugs

REGULATORY
18 Dec 2025
A new FDA pilot voucher could shrink review timelines for select obesity and diabetes drugs, stirring optimism and debate across the sector
they've attended our events
Expert Speakers
Vanessa Navarro
Danaher Corporation
Arjun Channi
Sanofi
Gulen Tonga
Tessera Therapeutics
Past Attendees
Danaher Corporation
Sanofi
Becton Dickinson
Tessera Therapeutics
Charles River
Inovio
Seran BioScience
Körber
Chiesi USA, Inc.













